BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17587340)

  • 1. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome.
    McLean-Tooke A; Spickett GP; Gennery AR
    Scand J Immunol; 2007 Jul; 66(1):1-7. PubMed ID: 17587340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological aspects of 22q11.2 deletion syndrome.
    Gennery AR
    Cell Mol Life Sci; 2012 Jan; 69(1):17-27. PubMed ID: 21984609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes.
    Sullivan KE; Jawad AF; Randall P; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH
    Clin Immunol Immunopathol; 1998 Feb; 86(2):141-6. PubMed ID: 9473376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome.
    Frank DU; Fotheringham LK; Brewer JA; Muglia LJ; Tristani-Firouzi M; Capecchi MR; Moon AM
    Development; 2002 Oct; 129(19):4591-603. PubMed ID: 12223415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic defects in 22q11.2 deletion syndrome.
    McLean-Tooke A; Barge D; Spickett GP; Gennery AR
    J Allergy Clin Immunol; 2008 Aug; 122(2):362-7, 367.e1-4. PubMed ID: 18485468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.
    Sullivan KE
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):438-44. PubMed ID: 11892070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune deficiency of chromosome 22q11.2 deletion syndrome.
    Morsheimer M; Brown Whitehorn TF; Heimall J; Sullivan KE
    Am J Med Genet A; 2017 Sep; 173(9):2366-2372. PubMed ID: 28627729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome.
    Gennery AR; Barge D; O'Sullivan JJ; Flood TJ; Abinun M; Cant AJ
    Arch Dis Child; 2002 Jun; 86(6):422-5. PubMed ID: 12023174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and molecular diagnosis of three patients with DiGeorge anomaly].
    Sun JQ; Wang LS; Qi CH; Ying WJ; Guo XH; Liu DR; Hui XY; Liu F; Cao Y; Luo FH; Wang XC
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):944-7. PubMed ID: 23324155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
    Kuo CY; Signer R; Saitta SC
    Curr Allergy Asthma Rep; 2018 Oct; 18(12):75. PubMed ID: 30377837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 22q11.2 deletion syndrome: immunological questions].
    Paśnik J; Cywińska-Bernas A; Piotrowicz M
    Postepy Hig Med Dosw (Online); 2007 Jun; 61():361-8. PubMed ID: 17572656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.
    Crowley B; Ruffner M; McDonald McGinn DM; Sullivan KE
    Am J Med Genet A; 2018 Oct; 176(10):2082-2086. PubMed ID: 29341423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunological spectrum of partial DiGeorge syndrome.
    Martin Mateos MA; Pérez Dueñas BP; Iriondo M; Krauel J; Gean Molins E
    J Investig Allergol Clin Immunol; 2000; 10(6):352-60. PubMed ID: 11206936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microdeletion 22q11: apropos of case of schizophrenia in an adolescent].
    Pinquier C; Héron D; de Carvalho W; Lazar G; Mazet P; Cohen D
    Encephale; 2001; 27(1):45-50. PubMed ID: 11294038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune status of the murine 22q11.2 deletion syndrome model.
    Crockett AM; Kebir H; Benallegue N; Adelman P; Gur RE; Sullivan K; Anderson SA; Alvarez JI
    Eur J Immunol; 2023 Jan; 53(1):e2249840. PubMed ID: 36337041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome.
    Sullivan KE
    Immunol Rev; 2019 Jan; 287(1):186-201. PubMed ID: 30565249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion.
    Brown JJ; Datta V; Browning MJ; Swift PG
    J Pediatr Endocrinol Metab; 2004 Nov; 17(11):1575-9. PubMed ID: 15570997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Sullivan KE; McDonald-McGinn D; Driscoll DA; Emanuel BS; Zackai EH; Jawad AF
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):906-11. PubMed ID: 10548584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.